Teva Files 2015 Annual Report on Form 20-F

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. SPY
6. RIVN
7. LMT
8. WMT
9. CMPS
10. NVDA

Go back to Teva Files 2015 Annual Report on Form 20-F

Mizuho Securities Cuts Price Target on Teva Pharma (TEVA) Following Slight 4Q EPS Miss

February 12, 2016 7:33 AM EST

Mizuho Securities reiterated a Buy rating on Teva Pharma (NYSE: TEVA), and cut the price target to $78.00 (from $79.00), following the company's 4Q earnings report. Teva reported a modest beat on revenues of $4.88B relative to consensus estimates of $4.84B, but missed bottom-line by a... More